Category Archives: Europe
Fragile X Syndrome Pipeline Analysis DelveInsight’s, “Fragile X Syndrome – Pipeline Insight, 2025,” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Fragile X Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical … Continue reading
Follicular Lymphoma Pipeline Insight DelveInsight’s, “Follicular Lymphoma – Pipeline Insight, 2025” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Follicular Lymphoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading
Excessive Daytime Sleepiness Pipeline Analysis DelveInsight’s, “Excessive Daytime Sleepiness – Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Excessive Daytime Sleepiness pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical … Continue reading
Corneal Endothelial Dystrophy Pipeline Analysis DelveInsight’s, “Corneal Endothelial Dystrophy – Pipeline Insight, 2025,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Corneal Endothelial Dystrophy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical … Continue reading
Cystinosis Pipeline Analysis DelveInsight’s, “Cystinosis- Pipeline Insight, 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Cystinosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics … Continue reading
Aneurysmal Subarachnoid Hemorrhage Pipeline Analysis DelveInsight’s, “Aneurysmal Subarachnoid Hemorrhage Pipeline Insight, 2025,” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Aneurysmal Subarachnoid Hemorrhage (ASH) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical … Continue reading
Alpha-1 Antitrypsin Deficiency Pipeline Insights DelveInsight’s, “Alpha1-Antitrypsin Deficiency (AATD) Pipeline Insight, 2025,” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Alpha1-Antitrypsin Deficiency (AATD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage … Continue reading
Warm Autoimmune Hemolytic Anemia (wAIHA) Pipeline Analysis Warm Autoimmune Hemolytic Anemia (wAIHA) companies are Fostamatinib, Immunovant Sciences GmbH, Apellis Pharmaceuticals, Inc., Bioverativ, and others. Warm Autoimmune Hemolytic Anemia (wAIHA) Pipeline constitutes 5+ key companies continuously working towards developing 5+ Warm … Continue reading
Osteosarcoma pipeline insights Osteosarcoma companies are Isofol Medical, Merck, Eisai Co Ltd, Jiangsu Hengrui Medicine, AstraZeneca, Y-mAbs Therapeutics, Innovent Biologics, PersonGen BioTherapeutics (Suzhou), Cellectar Biosciences, Inc., MacroGenics, Shanghai Pharmaceuticals Holding, Celgene, Hutchmed, MedImmune LLC, Lee’s Pharmaceutical Limited, EMD Serono, Iovance … Continue reading
DelveInsight’s “Eosinophilic Esophagitis Market Insight, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Eosinophilic Esophagitis historical and forecasted epidemiology as well as the Eosinophilic Esophagitis market trends in the United States, EU4 (Germany, France, Italy, … Continue reading